Author

Jocelin Huang

Institution: University of Minnesota

Observed institutions: Northwestern University, University of Minnesota, Mayo Clinic

OpenAlex ID: A5102368296

Risk factors for leukemic transformation in patients with primary myelofibrosis

2008 · Jocelin Huang, Chin‐Yang Li, et al. · Cancer · 126

Erythropoiesis stimulating agents have limited therapeutic activity in transfusion‐dependent patients with primary myelofibrosis regardless of serum erythropoietin level

2009 · Jocelin Huang, Ayalew Tefferi · European Journal Of Haematology · 90

Validation and comparison of contemporary prognostic models in primary myelofibrosis

2007 · Ayalew Tefferi, Jocelin Huang, et al. · Cancer · 67

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

2014 · Jocelin Huang, Suresh G. Nair, et al. · Clinical Colorectal Cancer · 46

Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains in Recent Years

2009 · Rakhee Vaidya, Sergio Siragusa, et al. · Mayo Clinic Proceedings · 20

Infection and Activation of B Cells by Theiler’s Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis

2020 · Young-Hee Jin, Charles X. Kim, et al. · Cells · 17

Morbidity and Mortality in Patients with Cancer who Become Nonambulatory after Spinal Cord Compression: A Case Series on End-of-Life Care

2009 · Jocelin Huang, Aminah Jatoi · Journal of Palliative Medicine · 14

Weight Loss, Splenomegaly, and Hypocholesterolemia in Myeloproliferative Neoplasms: Patterns and Relevance from the Pre JAK2 Inhibitor Era.

2009 · Ruben A. Mesa, Susan Schwager, et al. · Blood · 13

Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative Patients.

2007 · Ruben A. Mesa, Jocelin Huang, et al. · Blood · 13

Erythropoiesis Stimulating Agents and the Risk of Leukemic Transformation in Primary Myelofibrosis.

2007 · Jocelin Huang, Chin-Yang Li, et al. · Blood · 6

Low JAK2V617F Allele Burden in Primary Myelofibrosis, Compared to Either a Higher Allele Burden or Unmutated Status, Predicts Inferior Overall and Leukemia-Free Survival.

2007 · Ayalew Tefferi, Terra L. Lasho, et al. · Blood · 5

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

2008 · Ruben A. Mesa, Susan Schwager, et al. · Blood · 4

Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213)

2023 · Suzanne C. Danhauer, Emily V. Dressler, et al. · Integrative Cancer Therapies · 1

The Presence of the JAK2V617F Mutation in Primary Myelofibrosis and Its Allele Burden in Polycythemia Vera Predict Chemosensitivity to Hydroxyurea.

2007 · Shireen Sirhan, Jocelin Huang, et al. · Blood · 1

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

2008 · Ayalew Tefferi, Ruben A. Mesa, et al. · Blood

Erythropoietin Therapy Does Not Benefit Transfusion-Dependent Primary Myelofibrosis Patients and Treatment Response Is Infrequent with a Baseline Hemoglobin Level ≥ 10 g/dL.

2007 · Jocelin Huang, Terra L. Lasho, et al. · Blood

Works count: 16

Citation count: 423

H-index: 9

I10-index: 9